The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Convection Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Human Parkinson's disease
Objective/Rationale:
Infusion of neuroactive drugs into targeted nuclei of the basal ganglia involved in Parkinson’s disease should provide critical insight into the role of neurotransmitters in these... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Real-time Monitoring of Targeting, Delivery and Spread of Therapeutic Agents in the Brain
Objective/Rationale:
Current drug therapy for Parkinson’s disease has limited long term effectiveness. To improve therapy in the future, delivery of therapeutic agents to the brain will be an... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Deep brain imaging to determine movement of compounds relevant to Parkinson's disease
Objective/Rationale:
Clinical trials with a number of agents suggest that the ability of compounds to move through the interstitial spaces of the brain is a critical factor for their effectiveness... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Novel Antibodies for the Delivery of Parkinson's Therapeutics
Objective/Rationale:
Hindering drug development for neurological diseases like Parkinson’s disease is a lack of robust drug delivery strategies that can target medicines to the brain noninvasively via... -
Improving Delivery of Parkinson's Disease Therapeutics, 2008Utilizing Novel Tracers to Determine the Distribution of Therapeutic Agents In Vivo
Objective/Rationale:
This project will study the delivery and distribution of promising therapeutics for Parkinson’s disease. The explored compounds will be infused directly into the brain of npre... -
Improving Delivery of Parkinson's Disease Therapeutics to th, 2008Intranasal Delivery of GDNF for Parkinson's Disease: Next Steps
Objective/Rationale:
GDNF, a naturally-occurring growth factor capable of protecting and promoting the survival of dopamine neurons, has great potential as a treatment for Parkinson’s disease. However...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.